Cagrilintide 10mg

Description

Cagrilintide 10 mg is a long-acting amylin analogue under investigation in metabolic and satiety research. Amylin pathway research is a key area of study alongside incretin-based peptides.

Research Profile

• Long-acting amylin analogue
• Studied in satiety, gastric-emptying, and metabolic research models
• Often researched in combination with GLP-1 pathway compounds
• QC verified by HPLC and mass spectrometry

Specifications

• Compound: Cagrilintide
• Dosage: 10 mg per vial
• Purity: ≥ 98% (HPLC)
• Form: Lyophilized powder
• Storage: 2–8 °C (lyophilized); –20 °C (reconstituted)

For research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.